Millions of people in the developing world are in urgent need of the antiretroviral drugs that suppress HIV and postpone symptoms of AIDS, but the vast majority cannot afford them.
This report looks at the factors that prevent treatment for AIDS reaching the developing world, including costs, inadequate health care systems and the desire of pharmaceutical manufacturers to make large profits.
It also assesses the likelihood of a reduction in prices, through a combination of mechanisms that would allow countries to import or manufacture drugs at competitive rates.